Daniel Arias
Stock Analyst at Stifel
(5.00)
# 6
Out of 4,996 analysts
158
Total ratings
55.56%
Success rate
147.41%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $60 → $70 | $60.03 | +16.61% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $31.04 | +28.87% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $11.84 | +1.35% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $84.06 | +30.86% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $51.84 | +15.74% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $464.24 | +33.55% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $184.84 | +40.66% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $1.53 | +488.24% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $11.72 | +53.58% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $8.01 | -25.09% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,550 → $1,450 | $1,204.43 | +20.39% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $78.48 | -17.18% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $53.57 | +25.07% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $291.71 | +23.41% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $123.39 | +22.38% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $43.90 | +5.58% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.82 | +254.61% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $125.61 | +64.80% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $91.69 | +118.13% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.46 | +103.25% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.73 | +266.30% | 2 | May 31, 2022 |
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $60.03
Upside: +16.61%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $31.04
Upside: +28.87%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $11.84
Upside: +1.35%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $84.06
Upside: +30.86%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $51.84
Upside: +15.74%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $464.24
Upside: +33.55%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $184.84
Upside: +40.66%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.53
Upside: +488.24%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $11.72
Upside: +53.58%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $8.01
Upside: -25.09%
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,204.43
Upside: +20.39%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $78.48
Upside: -17.18%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $53.57
Upside: +25.07%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $291.71
Upside: +23.41%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $123.39
Upside: +22.38%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $43.90
Upside: +5.58%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.82
Upside: +254.61%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $125.61
Upside: +64.80%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $91.69
Upside: +118.13%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.46
Upside: +103.25%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.73
Upside: +266.30%